联合麻醉下行胸腹腔镜微创手术治疗食管癌的临床研究  

Clinical study of thoracic laparoscopic minimally invasive surgery under combined anesthesia for the treatment of esophageal cancer

作　　者：李涛[1] 

机构地区：[1]锦州市中心医院麻醉科,121000

出　　处：《中国现代药物应用》2018年第2期1-2,共2页Chinese Journal of Modern Drug Application

摘　　要：目的研究食管癌应用联合麻醉下行胸腹腔镜微创手术治疗的效果。方法 72例食管癌患者,按照抽签方法分为对照组和实验组,每组36例。对照组采用开胸手术治疗,实验组采用联合麻醉下行胸腹腔镜微创手术治疗,比较两组住院时间、并发症情况以及下床活动时间。结果实验组并发症发生率为5.56%,低于对照组的25.00%,差异有统计学意义(P<0.05)。实验组的住院时间(6.57±2.31)d、下床活动时间(2.58±1.24)d均短于对照组的(11.32±2.54)、(5.64±1.37)d,差异有统计学意义(P<0.05)。结论联合麻醉下行胸腹腔镜微创手术治疗食管癌效果显著,对于降低并发症发生率、维护患者健康意义重大。Objective To study the effect of thoracic laparoscopic minimally invasive surgery under combined anesthesia applied for the treatment of esophageal cancer. Methods A total of 72 esophageal cancer patients were divided by lottery method into control group and experimental group, with 36 cases in each group. The control group was treated with thoracotomy, and the experimental group was treated with thoracic laparoscopic minimally invasive surgery under combined anesthesia. Comparison were made on hospitalization time, complications and off-bed activity time between two groups. Results The experimental group had lower incidence of complications as 5.56% than 25.00% in the control group, and the difference was statistically significant （P〈0.05）. The experimental group had shorter hospitalization time as （6.57± 2.31） d and off-bed activity time as （2.58 ± 1.24） d than （11.32 ± 2.54） and （5.64 ±1.37） d in the control group, and their difference was statistically significant （P〈0.05）. Conclusion Thoracic laparoscopie minimally invasive surgery under combined anesthesia for the treatment of esophageal cancer shows remarkable effect and is of great significance for reducing the incidence of complications and maintaining the health of the patients.

关 键 词：食管癌 联合麻醉 胸腹腔镜微创手术 临床效果 

分 类 号：R614[医药卫生—麻醉学] R735.1[医药卫生—外科学]